Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical course of critical demyelinating lesion-associated progressive multiple sclerosis.

Journal of neurology·2026
Same author

Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

JAMA neurology·2026
Same author

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Perimetric Outcomes of Melbourne Rapid Field Perimetry in Patients With Glaucoma: A Systematic Review and Meta-Analysis.

Journal of glaucoma·2026
Same author

Immunity Gone Viral: Subacute Cognitive Decline With Multifocal Brain Lesions in Neuromyelitis Optica Spectrum Disorder.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

IL-6 Receptor Blockade as Rescue Therapy in Acute Attacks of MOGAD and AQP4+NMOSD.

JAMA neurology·2026

Related Experiment Video

Updated: Jul 12, 2026

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

Immune-mediated optic neuritis: A historical perspective.

Andres Inzunza1, Eoin P Flanagan2, John J Chen3

  • 1Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, United States; Massachusetts Eye and Ear, Department of Glaucoma, 243 Charles Street, Boston, MA 02114, United States.

Survey of Ophthalmology
|July 10, 2026
PubMed
Summary

Optic neuritis, an inflammatory optic neuropathy, has seen improved understanding and treatment due to scientific advances. Key discoveries in neuroimmunology and therapeutics have distinguished specific forms and enhanced patient outcomes.

Keywords:
Cell-based assaysHistory of medicineMagnetic resonance imagingMyelin oligodendrocyte glycoprotein antibody-associated diseaseNeuromyelitis opticaOptic neuritisOptical coherence tomography

More Related Videos

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

Related Experiment Videos

Last Updated: Jul 12, 2026

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

Area of Science:

  • Ophthalmology
  • Neuroimmunology
  • Neurology

Background:

  • Optic neuritis is an inflammatory optic neuropathy causing vision loss, eye pain, and dyschromatopsia.
  • It is frequently linked to immune-mediated neurological diseases.

Purpose of the Study:

  • To review the historical progression of understanding immune-mediated optic neuropathies.
  • To highlight key scientific and medical advancements that have shaped the diagnosis and treatment of optic neuritis.

Main Methods:

  • Review of historical scientific literature and landmark discoveries.
  • Chronological analysis of advancements in optics, neuroimaging, and molecular diagnostics.
  • Examination of therapeutic developments from cortisone to monoclonal antibodies.

Main Results:

  • Technological advances like MRI and OCT have refined optic neuritis classification.
  • Identification of specific antibodies (AQP4, MOG) has differentiated conditions like NMO and MOGAD from MS.
  • Development of targeted immunotherapies and clinical trials has significantly improved patient outcomes.

Conclusions:

  • The understanding of immune-mediated optic neuropathies has evolved significantly over two centuries.
  • Distinguishing specific disease entities has paved the way for personalized diagnostics and treatments.
  • Continued research in neuroimmunology and therapeutics promises further improvements in managing optic neuritis.